PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2511899122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jose A Rodriguez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Strang Laboratory of Apoptosis and Cancer Biology, The Rockefeller University, New York, NY 10065. Hauptthemen laut MEDLINE: F-Box Proteins, Parkinsonian Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Pershing Square Foundation (PSF), NIH HHS.
Abstract (Originalsprache)
Neurodegenerative diseases present one of the most significant global health challenges. These disorders are defined by the accumulation of abnormal protein aggregates that impair synaptic function and cause progressive neuronal degeneration. Therefore, stimulating protein clearance mechanisms may be neuro-protective. Variants in FBXO7/PARK15 cause Parkinsonian Pyramidal Syndrome, an early-onset parkinsonian neurodegenerative disorder in humans, and inactivation of this gene in mice recapitulates many phenotypes seen in patients. The proteasome regulator PI31 is a direct binding partner of Fbxo7 and promotes local protein degradation at synapses by mediating fast proteasome transport in neurites. PI31 protein levels are reduced when the function of Fbxo7 is impaired. Here we show that restoring PI31 levels in Fbxo7 mutant fly and mouse strains prevents neuronal degeneration and significantly improves neuronal function, health, and lifespan. Notably, Fbxo7 inactivation in mouse neurons causes hyperphosphorylation of tau, and this was suppressed by transgenic expression of PI31. Our results demonstrate that PI31 is a crucial biological target through which Fbxo7 deficiency drives pathology. Therefore, targeting the PI31-pathway may represent a promising therapeutic approach for treating neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Strang Laboratory of Apoptosis and Cancer Biology, The Rockefeller University, New York, NY 10065.
ORCID-Profile: Jose A Rodriguez, Rasha Aref, Hieu Hoang Minh Nguyen, Fiona Sun, Hermann Steller
Förderung
- NIGMS NIH HHS
- Pershing Square Foundation (PSF)
- NIH HHS
- NIH
Zitieren
APA
Rodriguez, J. A., Minis, A., Aref, R., Nguyen, H. H. M., Sun, F., & Steller, H. (2025). PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2511899122
Vancouver
Rodriguez JA, Minis A, Aref R, Nguyen HHM, Sun F, Steller H. PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2511899122
BibTeX
@article{Rodriguez2025,
author = {Rodriguez, Jose A and Minis, Adi and Aref, Rasha and Nguyen, Hieu Hoang Minh and Sun, Fiona and Steller, Hermann},
title = {PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2511899122}
}
EUVIMED